Acute Lymphoblastic Leukemia (ALL): Michael’s Experience

In this video, Michael, a father, chiropractor and actor, discusses his personal experience with Acute Lymphoblastic Leukemia, also known as ALL.
Learn More about Amgen Science:
www.amgenscience.com/
More about Amgen:
www.amgen.com/
Acute lymphoblastic leukemia (ALL) is a rare and rapidly progressing cancer of the blood and bone marrow - the spongy tissue inside bones where blood cells are made.
Most adult ALL patients relapse, and the median overall survival rate for those who do is three to five months. In 2015, an estimated 650 patients were diagnosed with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor ALL in the United States.
Find Amgen on the Web:
Facebook: bit.ly/35Xf09E
Instagram: bit.ly/2SYnTKJ
Twitter: bit.ly/2SW2cLq
LinkedIn: bit.ly/2xWbS17